J&J says second shot boosts protection for moderate-severe COVID-19 to 94%

Johnson & Johnson (JNJ.N) said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease.